Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 20, 2009, Pages 8296-8301

  Zarini, Simona ^a   Gijón, Miguel A ^a   Ransome, Aaron E ^a   Murphy, Robert C ^a   Sala, Angelo ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

5 lipoxygenase; Chimeric mice; Leukotriene B4; Leukotriene E4; Mass spectrometry

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; 5,6 DIHYDROXYEICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; AUTACOID; HYDROXY FATTY ACID; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE D4; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN; PROSTAGLANDIN E2; THROMBOXANE B2; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TRANSFER; CHIMERA; CONTROLLED STUDY; ENZYME DEFICIENCY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PERITONEUM LAVAGE; PERITONITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; TANDEM MASS SPECTROMETRY; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL COMMUNICATION; CYSTEINE; ENZYMES; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENES; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, TRANSGENIC; PERITONITIS; ZYMOSAN;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 66249141634     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0903851106     Document Type: Article

References (44)

1. Peters-Golden M, Henderson WR, Jr (2007) Leukotrienes, N Engl Med18:1841-1854.
2. Nicosia S, Capra V, Rovati GE (2001) Leukotrlenes as mediators of asthma. Pulm Pharmacol Ther 14:3-19.
3. De Caterina R, Zampolli A (2004) From asthma to atherosclerosis-5- lipoxygenase, leukotrlenes, and inflammation, N Engl J Med 350:4-7.
4. Zhao L, Funk CD (2004) Lipoxygenase pathways in atherogenesls, Trends Cardlovasc Med 14:191-195.
5. Fürstenberger G, Krieg P, Müller-Decker K, Habenicht A (2006) What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119:2247-2254.
6. Murphy RC Gijón MA (2007) Biosynthesis and metabolism of leukotrienes, Biochem J 405:379-395.
7. Steinhilber D (1994) 5-Lipoxygenase: Enzyme expression and regulation of activity, Pharm Acta Helv 69:3-14.
8. Rådmark O, Werz O, Steinhilber D, Samuelsson B (2007) 5-Lipoxygenase: Regulation of expression and enzyme activity, Trends Biochem Sci 32:332-341.
9. z. J Lipid Mediat Cell Signal 12:83-117.
10. Peters-Golden M, Brock TG (2000) Intracellular compartmentallzatlon of leukotriene biosynthesis, Am J Respir Crit Care Med 161 :S36-S40.
11. Woods JW, et al. (1993) 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes, J Exp Med 178:19351946.
12. Mandal AK, et al. (2008) The nuclear membrane organization of leukotriene synthesis, Proc Natl Acad Sci USA 105:20434-20439.
13. 4 that mediates Chemotaxis, Nature 387:620-624.
14. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T (2000) A second leukotriene B(4) receptor, BLT2, A new therapeutic target in inflammation and Immunological disorders, J Exp Med 192:421-432.
15. Lynch KR, et al. (1999) Characterization of the human cysteinyl leukotriene CysLTI receptor, Nature 399:789-793.
16. Heise CE, et al. (2000) Characterization of the human cysteinyl leukotriene 2 receptor, J Biol Chem 275:30531-30536.
17. Clana P, et al. (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor, EMBO J 25:4615-4627.
18. 4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors, Proc Natl Acad Sci USA 105:16695-16700.
19. Funk CD (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease, Nat Rev Drug Discov 4:664-672.
20. Evans JF, Ferguson AD, Mosley RT, Hutchinson JH (2008) What's all the FLAP about?; 5-lipoxygenase-activating protein inhibitors for inflammatory diseases, Trends Pharmacol Sci 29:72-78.
21. Uhl J, et al. (2002) The 5-lipoxygenase promoter is regulated by DNA methylatlon, J Biol Chem 277:4374-4379.
22. Flamand N, Lefebvre J, Surette ME, Picard S, Borgeat P (2006) Arachidonic add regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils, J Biol Chem 281:129-136.
23. 4. J Biol Chem 263:174-181.
24. Folco G, Murphy RC (2006) Eicosanoid transcellular biosynthesis: From cell-cell interactions to in vivo tissue responses, Pharmacol Rev 58:375-388.
25. 4 J Biol Chem 257:4680-4683.
26. Fabre JE, et al. (2002) Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo, J Clin Invest 109:1373-1380.
27. Mullaly SC, Kubes P (2007) Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis, Eur J Immunol 37:224-234.
28. Rao TS, Currle JL, Shaffer AF, lsakson PC (1994) in vivo characterization of zymosanlnduced mouse peritoneal inflammation, J Pharmacol Exp Ther 269:917-925.
29. Gijón MA, Zarini S, Murphy RC (2007) Biosynthesis of elcosanolds and transcellular metabolism of leukotrienes in murine bone marrow cells, J Lipid Res 48:716-725.
30. Prakash H, Bala M, Ali A, Goel HC (2005) Modification of gamma radiation induced response of peritoneal macrophages and splenocytes by Hippophae rhamnoldes (RH-3) in mice, J Pharm Pharmacol 57:1065-1072.
31. Soule BP, et al, (2007) Effects of gamma radiation on Fc.Ri and TLR-medlated mast cell activation, J Immunol 179:3276-3286.
32. WhelanJ, Golemboski KA, Broughton KS, Kinsella JE, Dletert RR (1997) Characterization of leukotriene production in vivo and in vitro in resident and elicited peritoneal macrophages in chickens and mice, Prostaglandins Leukot Essent Fatty Acids 56:41-49.
33. Kolaczkowska E, Shahzidi S, Seljelid R, van Rooljen N, Plytycz B (2002) Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cystelnylleukotrlenes, Inflammation 26:61-71.
34. 4 hydrolase-deflcient mice, J Immunol 163:6810-6819.
35. 4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo, J Pharmacol Exp Ther 307:1072-1078.
36. McCurdy JD, Olynych TJ, Maher LH, Marshall JS (2003) Cutting edge: Distinct Toll-like receptor 2 activators selectively Induce different classes of mediator production from human mast cells, J Immunol 170:1625-1629.
37. Borgeat P, Samuelsson B (1979) Arachidonic add metabolism in polymorphonuclear leukocytes: Unstable Intermediate in formation of dlhydroxy acids, Proc Natl Acad Sci USA 76:3213-3217.
38. 4 synthase, J Biol Chem 271:22203-22210.
39. 4 in different human tissues is attributable to distinct membrane bound biosynthetic enzymes, J Biol Chem 272:10182-10187.
40. Sala A, Zarini S, Folco G, Murphy RC, Henson PM (1999) Differential metabolism of exogenous and endogenous arachidonic add in human neutrophils, J Biol Chem 274:28264-28269.
41. Di Gennaro A, et al. (2004) Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: A role for transcellular biosynthesis of cysteinyl-leukotrienes, FASEB J 18:842-844.
42. 4 from human polymorphonuclear leukocytes, J Biol Chem 271:17944-17948.
43. Goulet JL, Snouwaert JN, Latour AM, Coffman TM, Koller BH (1994) Altered inflammatory responses in leukotriene-deficient mice, Prec Natl Acad Sci USA 91:1285212856.
44. 4 synthase, J Biol Chem 276:22608-22613.